Celgene Corp (CELG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CELG | REGN | GSK | ||
| Company | Celgene Corp | Regeneron Pharmaceuticals | Gsk Plc ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 108.01 | 744.70 | 33.83 | ||
| High | 108.59 | 751.40 | 34.15 | ||
| Low | 107.27 | 737.63 | 33.76 | ||
| Last | 108.24 | 738.00 | 33.96 | ||
| Change | +0.11 | -6.50 | +0.26 | ||
| % Change | +0.10% | -0.87% | +0.77% | ||
| Volume | 191,230,496 | 1,029,500 | 4,173,300 | ||
| 20-Day Average Volume | 16,188,930 | 897,610 | 8,435,345 | ||
| Previous Close | 108.13 | 744.50 | 33.70 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 108.17 | 815.56 | 35.62 | ||
| 20-Day Raw Stochastic | 63.25% | 0.99% | 20.90% | ||
| 20-Day Relative Strength | 64.69% | 16.20% | 32.62% | ||
| Weighted Alpha | +46.30 | -23.09 | -14.54 | ||
| Today's Opinion | 100% Buy | 88% Sell | 100% Sell | ||
| Previous Opinion | 100% Buy | 88% Sell | 100% Sell | ||
| Last Month's Opinion | 100% Buy | 40% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.97% since 11/13/19 | -2.49% since 11/15/24 | +1.83% since 11/15/24 | ||
| Low | 107.27 on 11/20/19 | 735.95 on 11/21/24 | 33.17 on 11/21/24 | ||
| High | 110.53 on 11/14/19 | 762.70 on 11/18/24 | 34.15 on 11/22/24 | ||
| 1-Month | |||||
| %Chg | +5.14% since 10/18/19 | -23.31% since 10/22/24 | -10.63% since 10/22/24 | ||
| Low | 102.40 on 10/21/19 | 735.95 on 11/21/24 | 32.83 on 11/15/24 | ||
| High | 110.70 on 11/13/19 | 959.60 on 10/23/24 | 38.26 on 10/29/24 | ||
| 3-Month | |||||
| %Chg | +13.63% since 08/20/19 | -37.86% since 08/22/24 | -19.05% since 08/22/24 | ||
| Low | 93.41 on 08/23/19 | 735.95 on 11/21/24 | 32.83 on 11/15/24 | ||
| High | 110.70 on 11/13/19 | 1,211.20 on 08/27/24 | 44.67 on 08/27/24 | ||
| 6-Month | |||||
| %Chg | +14.14% since 05/20/19 | -24.98% since 05/22/24 | -25.82% since 05/22/24 | ||
| Low | 89.08 on 07/23/19 | 735.95 on 11/21/24 | 32.83 on 11/15/24 | ||
| High | 110.70 on 11/13/19 | 1,211.20 on 08/27/24 | 45.77 on 05/23/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 77,035,920 | 81,098,816 | 70,383,800 | ||
| Shares Outstanding, K | 711,714 | 109,890 | 2,072,550 | ||
| Annual Sales | 15,281,000,000 | 13,117,200,000 | 37,725,000,000 | ||
| Annual Net Income | 4,046,000,000 | 3,953,600,000 | 6,129,940,000 | ||
| Last Quarter Sales | 4,520,000,000 | 3,720,700,000 | 10,420,410,000 | ||
| Last Quarter Net Income | 1,691,000,000 | 1,340,600,000 | -75,430,000 | ||
| 60-Month Beta | 1.41 | 0.15 | 0.66 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.99 on 10/31/19 | 12.46 on 10/31/24 | 1.27 on 10/30/24 | ||
| Latest Earnings Date | 10/31/19 | 10/31/24 | 10/30/24 | ||
| Most Recent Dividend | N/A | N/A | 0.382 on 11/15/24 | ||
| Next Ex-Dividends Date | N/A | N/A | 11/15/24 | ||
| Ratios | |||||
| Price/Earnings ttm | 10.99 | 18.62 | 8.08 | ||